HCA Holdings, Inc. (NYSE:HCA) – Research analysts at Leerink Swann decreased their FY2017 EPS estimates for shares of HCA Holdings in a research note issued on Wednesday. Leerink Swann analyst A. Gupte now anticipates that the company will earn $7.12 per share for the year, down from their previous estimate of $7.34. Leerink Swann currently has a “Outperform” rating and a $100.00 target price on the stock. Leerink Swann also issued estimates for HCA Holdings’ Q4 2017 earnings at $1.99 EPS.

HCA Holdings (NYSE:HCA) last posted its earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.80 by $0.05. The business had revenue of $10.73 billion for the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.66 earnings per share. COPYRIGHT VIOLATION NOTICE: “FY2017 EPS Estimates for HCA Holdings, Inc. Reduced by Leerink Swann (NYSE:HCA)” was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/07/27/fy2017-eps-estimates-for-hca-holdings-inc-reduced-by-leerink-swann-nysehca.html.

A number of other research firms also recently issued reports on HCA. Argus started coverage on shares of HCA Holdings in a report on Wednesday, June 28th. They issued a “buy” rating and a $100.00 target price for the company. Zacks Investment Research downgraded shares of HCA Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, April 18th. Bank of America Corporation downgraded shares of HCA Holdings from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $102.00 to $92.00 in a research note on Wednesday. BidaskClub downgraded shares of HCA Holdings from a “hold” rating to a “sell” rating in a research note on Monday. Finally, Morgan Stanley started coverage on shares of HCA Holdings in a research note on Tuesday, June 6th. They set an “equal weight” rating and a $90.00 price objective for the company. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $92.67.

HCA Holdings (NYSE:HCA) traded down 1.329% on Thursday, reaching $80.545. 381,398 shares of the company were exchanged. The stock has a 50-day moving average price of $85.32 and a 200 day moving average price of $84.43. HCA Holdings has a 52 week low of $67.00 and a 52 week high of $91.03. The stock has a market capitalization of $29.55 billion, a price-to-earnings ratio of 10.944 and a beta of 0.69.

In related news, insider Jonathan B. Perlin sold 71,063 shares of the company’s stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $86.00, for a total value of $6,111,418.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $86.44, for a total transaction of $185,846.00. Following the completion of the sale, the insider now directly owns 12,363 shares in the company, valued at $1,068,657.72. The disclosure for this sale can be found here. Over the last three months, insiders have sold 397,424 shares of company stock worth $33,234,810. Corporate insiders own 2.90% of the company’s stock.

Hedge funds have recently bought and sold shares of the stock. Sumitomo Life Insurance Co. boosted its stake in HCA Holdings by 150.7% in the second quarter. Sumitomo Life Insurance Co. now owns 22,801 shares of the company’s stock valued at $1,988,000 after buying an additional 13,706 shares in the last quarter. Longview Partners Guernsey LTD boosted its stake in HCA Holdings by 4.8% in the second quarter. Longview Partners Guernsey LTD now owns 9,081,454 shares of the company’s stock valued at $791,903,000 after buying an additional 414,598 shares in the last quarter. FineMark National Bank & Trust boosted its stake in HCA Holdings by 5.2% in the second quarter. FineMark National Bank & Trust now owns 38,640 shares of the company’s stock valued at $3,369,000 after buying an additional 1,922 shares in the last quarter. Strs Ohio boosted its stake in HCA Holdings by 15.5% in the second quarter. Strs Ohio now owns 958,778 shares of the company’s stock valued at $83,605,000 after buying an additional 128,445 shares in the last quarter. Finally, Shell Asset Management Co. boosted its stake in HCA Holdings by 36.9% in the second quarter. Shell Asset Management Co. now owns 61,055 shares of the company’s stock valued at $5,324,000 after buying an additional 16,462 shares in the last quarter. 74.48% of the stock is currently owned by hedge funds and other institutional investors.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Earnings History and Estimates for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.